A new micro enzyme-linked-immunosorbent-assay (ELISA) effectively monitors human proinsulin (hPI) in serum. This assay is valuable for diagnosing insulinoma and assessing beta-cell function, though not sensitive enough for IDDM patients.
Area of Science:
Biochemistry
Immunology
Endocrinology
Background:
Circulating human proinsulin (hPI) is a key biomarker in metabolic and endocrine disorders.
Accurate monitoring of hPI levels is crucial for understanding beta-cell function and diagnosing conditions like insulinoma.
Existing immunoassays may lack the sensitivity or specificity required for comprehensive hPI analysis.
Purpose of the Study:
To develop and validate a sensitive micro enzyme-linked-immunosorbent-assay (ELISA) for quantifying circulating human proinsulin (hPI).
To establish the assay's performance characteristics, including detection limit, operating range, and specificity.
To evaluate the assay's utility in clinical settings, such as diagnosing insulinoma and assessing beta-cell function.
Main Methods:
A micro ELISA was developed using guinea pig anti-insulin antibody-coated plates and peroxidase-labelled F(ab')2-fragments of guinea pig anti-human C-peptide as the detection system.
Assay sensitivity, specificity, and intra-assay variation were determined using buffer and serum samples.
Cross-reactivity studies were performed with insulin, human C-peptide, and proinsulins from other species.
The assay was applied to samples from healthy subjects, pancreatectomized patients, and an insulinoma patient.
Main Results:
The assay demonstrated a detection limit of 1.2 pmol/l in serum (50% dilution) with a standard operating range of 0-160 pmol/l.
Interassay variation was 9%, and significant cross-reactivity was not observed with insulin, human C-peptide, or porcine/bovine proinsulins.
Reference ranges in healthy subjects were 1.2-13 pmol/l (median 4.1 pmol/l), while pancreatectomized patients showed values below the detection limit, and an insulinoma patient had 263 pmol/l.
Conclusions:
The developed micro ELISA is a sensitive and specific method for monitoring circulating human proinsulin (hPI).
The assay is useful for diagnosing insulinoma and characterizing beta-cell function in stimulated conditions.
While not sensitive enough for fasting IDDM patients, it offers valuable clinical insights in other endocrine contexts.